If you or your child has developed narcolepsy following administration of the Pandemrix Swine Flu vaccine, you may have grounds to pursue a legal claim. Michael Boylan Litigation's specialist narcolepsy solicitors have acted for over 80 narcolepsy cases, including the test case and other lead cases, involving both adults and children affected by narcolepsy arising from Pandemrix.
Each case turns on its own facts, and the path forward depends on your vaccination history, medical records and individual timeline. If you believe your narcolepsy may be connected to Pandemrix, obtaining legal advice based on your specific circumstances is an important first step.
The Irish Background to Pandemrix and Narcolepsy
The 2009 and 2010 vaccination period
In 2009, the World Health Organisation declared a Swine Flu pandemic. In response, the Irish Government and the HSE launched a national vaccination programme beginning in October 2009. The HSE purchased the Pandemrix vaccine from GlaxoSmithKline (GSK) by contract in May 2009. The vaccine was largely untested at the time of purchase. GSK received a full and comprehensive indemnity from the HSE against all narcolepsy claims on signing that contract.
Over 900,000 people in Ireland were vaccinated with Pandemrix. Most recipients were vaccinated between 25 October 2009 and 31 March 2010. Pandemrix was an adjuvanted vaccine containing the adjuvant AS03, which makes the immune system more reactive to the core virus. Less antigen is required once the adjuvant is added. The alternative vaccine available on the market, Celvapan (manufactured by Baxter), did not contain an adjuvant.
A strong media campaign run by the HSE encouraged the public to receive the Swine Flu vaccine. However, the HSE campaign did not distinguish between the adjuvanted and unadjuvanted vaccines and did not advise the public that Pandemrix was a largely untested product.
The withdrawal of Pandemrix from the Irish market
Pandemrix was withdrawn from the Irish market on or around April 2011. It is important to note that in some cases, Pandemrix was used after March 2010 as a substitute for the ordinary flu vaccine where stocks were scarce. This means the relevant vaccination window is not always limited to the October 2009 to March 2010 period.
Identifying the exact vaccine received and the date of administration is a critical part of any factual investigation.
The HSE report and increased risk finding
A report carried out by the HSE in 2012 found that recipients of the Pandemrix Swine Flu vaccine were thirteen times more likely to develop narcolepsy than unvaccinated individuals. Similar findings were recorded in Sweden and Finland.
Despite receiving reports from GSK as early as December 2009 detailing serious adverse events arising from Pandemrix, including convulsions and neurological conditions, the vaccination programme continued without review or modification by the HSE or the Irish Medicines Board (now the Health Products Regulatory Authority, HPRA).
It is estimated that approximately 3,000 people across Europe have been affected by narcolepsy arising from the Pandemrix vaccine, many of whom have been compensated. To date, no offer of compensation has been made to Irish recipients of the Pandemrix vaccine who developed narcolepsy. In most cases, only a discretionary medical card has been facilitated.
What Is Narcolepsy and How Can It Affect Daily Life?
Common symptoms reported in narcolepsy cases
Narcolepsy is a long-term neurological condition that affects the brain's ability to regulate normal sleep and wake cycles. Common symptoms include:
- Excessive daytime sleepiness: An overwhelming and persistent need to sleep during the day, regardless of how much rest a person has had.
- Sudden sleep episodes: Falling asleep unexpectedly and without warning, sometimes in the middle of an activity.
- Sleep paralysis: A temporary inability to move or speak when falling asleep or waking up.
- Hallucinations: Vivid and sometimes frightening sensory experiences, often occurring as a person drifts in and out of sleep.
- Disrupted night-time sleep: Frequent waking during the night, despite significant daytime tiredness.
Narcolepsy with cataplexy
Many people with narcolepsy also experience cataplexy. This involves a sudden loss of muscle tone or muscle weakness, usually triggered by strong emotions such as laughter, surprise or frustration. During an episode, a person may experience anything from a slight weakness in the face or knees to a full physical collapse.
Cataplexy can create real practical dangers, including the risk of falling or losing control of movement at unpredictable moments. It can also cause significant embarrassment and anxiety, particularly for children and young people in school or social settings.
The long-term practical impact
Narcolepsy is a lifelong, incurable condition and its effects reach well beyond sleep. The areas most commonly affected include:
- Education: Difficulty concentrating, staying awake in class and completing exams.
- Employment: Challenges in maintaining consistent performance, safety concerns in certain roles and difficulties securing or keeping work.
- Driving: Narcolepsy can affect a person's ability to hold a driving licence, limiting independence.
- Social and family life: Withdrawal from activities, strained relationships and reliance on others for support.
- Ongoing treatment: Most people with narcolepsy require long-term medication and lifestyle adjustments to manage their symptoms.
What Evidence May Be Relevant in a Narcolepsy and Pandemrix Matter?
Vaccination records
- Confirmation that Pandemrix was administered: Including the specific vaccine name, batch number where available and the date of administration.
- Location of vaccination: Whether this was a GP surgery, school, HSE centre or hospital clinic.
- GP, school or HSE records: That document the vaccination.
Medical diagnosis and treatment records
- GP notes: Documenting early symptoms and referrals.
- Neurology records: From specialist consultations and ongoing treatment.
- Sleep clinic reports: Including polysomnography and other diagnostic tests.
- Medication history: Records of prescribed treatments for narcolepsy symptoms.
- Hospital records: Where relevant to the diagnosis or related conditions.
Records showing the effect on education, work and daily life
- School reports and college records: Showing changes in attendance, performance or the need for accommodations.
- Employment records: Including occupational health assessments, absences or changes in role.
- Social welfare or support documentation: Where relevant to the person's circumstances.
- Family observations: Particularly where symptoms began when the affected person was a child, a parent's account of changes in behaviour, sleep patterns and daily functioning can be significant.
Time Limits
Limitation periods in narcolepsy cases can be complex. There is no single rule that applies to every situation. The time limits that apply to a particular case will depend on its own facts, and several factors can affect when time begins to run. These include situations where the affected person was a child at the time of vaccination, where diagnosis was delayed, or where the connection with Pandemrix only became apparent at a later stage.
Dates that may need to be considered
- Date of vaccination.
- Date symptoms first appeared.
- Date of diagnosis.
- Date the possible connection with Pandemrix became known.
- Date any previous legal advice was obtained.
Because of this complexity, advice on time limits should always be based on the person's own timeline and circumstances. If you are unsure whether you are still within time, it is important to seek legal advice promptly.
Questions people often have about narcolepsy and Pandemrix legal matters
Can narcolepsy be linked to the Pandemrix Swine Flu vaccine?
The HSE's own 2012 report found that recipients of Pandemrix were thirteen times more likely to develop narcolepsy than unvaccinated individuals. Whether a particular person's narcolepsy can be linked to Pandemrix in a legal context depends on their individual records, vaccination timeline and medical evidence. This is assessed on a case-by-case basis.
What if I was vaccinated after March 2010?
Pandemrix was used in some cases after March 2010 as a substitute for the ordinary flu vaccine where stocks were scarce. The vaccine was not withdrawn from the Irish market until approximately April 2011. If you received Pandemrix outside the main vaccination window, your case can still be assessed on its own facts.
Can adults and children both be affected?
Yes. Michael Boylan Litigation's narcolepsy work includes both adults and children affected by narcolepsy arising from Pandemrix.
What documents should I try to locate?
If you are considering seeking legal advice, it is helpful to gather as many of the following as possible:
- Vaccination records (from your GP, school or HSE).
- GP notes and referral letters.
- Neurology and sleep clinic reports.
- School reports or employment records showing any change in performance or attendance.
- Any previous correspondence with solicitors, the HSE or other bodies about your narcolepsy.
Does every narcolepsy diagnosis give rise to a legal case?
Not necessarily. Whether a legal case arises depends on the vaccination history, the timing between vaccination and symptoms, the diagnosis itself, medical evidence and a full legal assessment of the individual circumstances. A diagnosis of narcolepsy is an important starting point, but it is not sufficient on its own.
Who might be involved in a Pandemrix-related legal case?
Depending on the facts of the case, parties such as GlaxoSmithKline (GSK), the HSE, the Minister for Health and the Health Products Regulatory Authority (HPRA), formerly the Irish Medicines Board, may all need to be considered. The relevant parties will depend on the individual circumstances of each case.
Speak With Michael Boylan Litigation About Narcolepsy and Pandemrix
If you or your child has been affected by narcolepsy, or if you believe the development of narcolepsy may be connected to the Pandemrix Swine Flu vaccine administered between October 2009 and the end of March 2010, or later, and you wish to investigate the matter further, please do not hesitate to contact Michael Boylan Litigation.
Each person's situation is different, and the appropriate next step depends on your own history and timeline. Speaking with a solicitor experienced in this area is the most effective way to understand your position.
*In contentious business, a solicitor may not calculate fees or other charges as a percentage or proportion of any award or settlement.
